Citations (13)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Andrew C. Axilrod. (2007) Phosphodiesterase type 5 inhibitor therapy: identifying and exploring what attributes matter more to clinicians and patients in the management of erectile dysfunction. Current Medical Research and Opinion 23:12, pages 3189-3198.
Read now
Read now
Articles from other publishers (12)
H. Alidu, N. Amidu, W. K. B. A. Owiredu, C. K. Gyasi-Sarpong, A. T. Bawah, P. P. M. Dapare & E. B. Agyemang Prempeh. (2017) Testosterone and Its Bioactive Components Are Associated with Libido and the Metabolic Syndrome in Men. Advances in Sexual Medicine 07:02, pages 105-119.
Crossref
Crossref
Juraj Fillo, Jan Breza, Michaela Levčíkova, Jan Luha, Anna Vachulova, Štefan Durdík & Peter Labaš. (2012) Occurrence of erectile dysfunction, testosterone deficiency syndrome and metabolic syndrome in patients with abdominal obesity. Where is a sufficient level of testosterone?. International Urology and Nephrology 44:4, pages 1113-1120.
Crossref
Crossref
N. BAR-CHAMA, S. SNYDER & L. ALEDORT. (2011) Sexual evaluation and treatment of ageing males with haemophilia. Haemophilia 17:6, pages 875-883.
Crossref
Crossref
Kew-Kim Chew, Nicholas Gibson, Frank Sanfilippo, Bronwyn Stuckey & Alexandra Bremner. (2011) Cardiovascular Mortality in Men with Erectile Dysfunction: Increased Risk But Not Inevitable. The Journal of Sexual Medicine 8:6, pages 1761-1771.
Crossref
Crossref
Martin M. Miner, Allison Barnes & Stephen Janning. (2010) Efficacy of Phosphodiesterase Type 5 Inhibitor Treatment in Men with Erectile Dysfunction and Dyslipidemia: A Post Hoc Analysis of the Vardenafil Statin Study. The Journal of Sexual Medicine 7:5, pages 1937-1947.
Crossref
Crossref
Kew-Kim Chew, Judith Finn, Bronwyn Stuckey, Nicholas Gibson, Frank Sanfilippo, Alexandra Bremner, Peter Thompson, Michael Hobbs & Konrad Jamrozik. (2010) Erectile Dysfunction as a Predictor for Subsequent Atherosclerotic Cardiovascular Events: Findings from a Linked-Data Study. The Journal of Sexual Medicine 7:1, pages 192-202.
Crossref
Crossref
Ajay Nehra. (2009) Erectile Dysfunction and Cardiovascular Disease: Efficacy and Safety of Phosphodiesterase Type 5 Inhibitors in Men With Both Conditions. Mayo Clinic Proceedings 84:2, pages 139-148.
Crossref
Crossref
Martin Miner, Larry Gilderman, James Bailen, David Cook, Katie Dawson, Marisha Stanislaus, Eric Beresford & Allison Barnes. (2008) Vardenafil in Men with Stable Statin Therapy and Dyslipidemia. The Journal of Sexual Medicine 5:6, pages 1455-1467.
Crossref
Crossref
Martin Miner & Kevin L. Billups. (2008) Erectile Dysfunction and Dyslipidemia: Relevance and Role of Phosphodiesterase Type-5 Inhibitors and Statins. The Journal of Sexual Medicine 5:5, pages 1066-1078.
Crossref
Crossref
M. T. Rosenberg. (2007) Diagnosis and management of erectile dysfunction in the primary care setting. International Journal of Clinical Practice 61:7, pages 1198-1208.
Crossref
Crossref
Inês Tomada, Nuno Tomada & Pedro Vendeira. (2007) Disfunção eréctil e obesidade. Revista Internacional de Andrología 5:3, pages 284-288.
Crossref
Crossref
Mark A Moyad, James H Barada, Tom F Lue, John P Mulhall, Irwin Goldstein & Ahmed Fawzy. (2004) Prevention and treatment of erectile dysfunction using lifestyle changes and dietary supplements: what works and what is worthless, part I. Urologic Clinics of North America 31:2, pages 249-257.
Crossref
Crossref